BAO LING PAULINE SOH: Open Payments
NPI 1033605944 · BOLINGBROOK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,905 in 145 payments from 17 companies in 2025. Trend: 2023 $1,315 · 2024 $2,956 · 2025 $2,905
Food & beverage: $2,901Education: $4
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $526 |
| Otsuka America Pharmaceutical, Inc. | 24 | $440 |
| Janssen Pharmaceuticals, Inc | 22 | $424 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $398 |
| Tris Pharma Inc | 8 | $189 |
| Vanda Pharmaceuticals Inc. | 7 | $181 |
| Lundbeck LLC | 7 | $146 |
| Teva Pharmaceuticals USA, Inc. | 6 | $118 |
| Collegium Pharmaceutical, Inc. | 5 | $116 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $81 |
Products named: REXULTI, VRAYLAR, CAPLYTA, SPRAVATO, INVEGA SUSTENNA, FANAPT, Dyanavel XR, Jornay PM.
Industry payments across IL — which companies pay providers there.
